Investing.com - vTv Therapeutics Inc reported on Thursday third quarter earnings that matched analysts' forecasts and revenue that topped expectations.
vTv Therapeutics Inc announced earnings per share of $-0.050 on revenue of $250K. Analysts polled by Investing.com anticipated EPS of $-0.050 on revenue of $0.
vTv Therapeutics Inc shares are down 53.92% from the beginning of the year , still down 41.03% from its 52 week high of $1.56 set on Wednesday, November 17, 2021.
vTv Therapeutics Inc follows other major Healthcare sector earnings this month
vTv Therapeutics Inc's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar